C
Takeda Pharmaceutical Company Limited TAK
$14.16 $0.443.21% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 7.66B 6.91B 7.50B 7.91B 7.75B
Total Other Revenue -- -- -- -- --
Total Revenue 7.66B 6.91B 7.50B 7.91B 7.75B
Cost of Revenue 2.66B 2.45B 2.73B 2.65B 2.48B
Gross Profit 5.00B 4.46B 4.77B 5.26B 5.27B
SG&A Expenses 1.77B 1.94B 1.77B 1.80B 1.73B
Depreciation & Amortization 895.50M 895.87M 879.81M 934.19M 889.41M
Other Operating Expenses 41.76M -598.86M 958.94M -298.11M 342.49M
Total Operating Expenses 6.37B 6.10B 7.46B 6.28B 6.53B
Operating Income 1.29B 807.22M 39.68M 1.64B 1.22B
Income Before Tax 1.04B -704.08M 173.16M 803.13M 876.40M
Income Tax Expenses 182.45M -27.57M 16.87M 183.44M 264.99M
Earnings from Continuing Operations 860.47M -676.51M 156.29M 619.69M 611.41M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -249.30K -374.00K -301.60K -410.40K -327.20K
Net Income 860.22M -676.88M 155.99M 619.28M 611.08M
EBIT 1.29B 807.22M 39.68M 1.64B 1.22B
EBITDA 2.55B 1.45B 1.27B 2.93B 2.46B
EPS Basic 0.55 -0.43 0.10 0.39 0.39
Normalized Basic EPS 0.42 0.26 -0.09 0.52 0.41
EPS Diluted 0.54 -0.43 0.10 0.38 0.38
Normalized Diluted EPS 0.42 0.26 -0.09 0.51 0.41
Average Basic Shares Outstanding 1.56B 1.58B 1.59B 1.58B 1.57B
Average Diluted Shares Outstanding 1.59B 1.58B 1.59B 1.61B 1.59B
Dividend Per Share -- 0.64 0.00 0.66 --
Payout Ratio 116.94% -9.44% 611.42% 9.99% 145.00%